Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

MicroRNA-200c as a prognostic and sensitivity marker for platinum chemotherapy in advanced gastric cancer.

Li M, Gu K, Liu W, Xie X, Huang X.

Oncotarget. 2017 Apr 13;8(31):51190-51199. doi: 10.18632/oncotarget.17087. eCollection 2017 Aug 1.

2.

Sarcopenia related to neoadjuvant chemotherapy and perioperative outcomes in resected gastric cancer: a multi-institutional analysis.

Mirkin KA, Luke FE, Gangi A, Pimiento JM, Jeong D, Hollenbeak CS, Wong J.

J Gastrointest Oncol. 2017 Jun;8(3):589-595. doi: 10.21037/jgo.2017.03.02.

3.

Mortality differences by surgical volume among patients with stomach cancer: a threshold for a favorable volume-outcome relationship.

Choi H, Yang SY, Cho HS, Kim W, Park EC, Han KT.

World J Surg Oncol. 2017 Jul 17;15(1):134. doi: 10.1186/s12957-017-1203-7.

4.

Evolution in the surgical management of gastric cancer: is extended lymph node dissection back in vogue in the USA?

Chen T, Yan D, Zheng Z, Yang J, Dong XDE.

World J Surg Oncol. 2017 Jul 17;15(1):135. doi: 10.1186/s12957-017-1204-6. Review.

5.

Recurrent gastric cancer metastasizing to the bone marrow: A case report of a rare presentation.

Fonocho E, Aydin N, Reddy S, Misra S.

Int J Surg Case Rep. 2017;37:165-168. doi: 10.1016/j.ijscr.2017.06.025. Epub 2017 Jun 24.

6.

Distal gastrectomy versus total gastrectomy for distal gastric cancer.

Liu Z, Feng F, Guo M, Liu S, Zheng G, Xu G, Lian X, Fan D, Zhang H.

Medicine (Baltimore). 2017 Feb;96(5):e6003. doi: 10.1097/MD.0000000000006003.

7.

Potentially Curable Cancers of the Esophagus and Stomach.

Elimova E, Mizrak Kaya D, Harada K, Ajani JA.

Mayo Clin Proc. 2016 Sep;91(9):1307-18. doi: 10.1016/j.mayocp.2016.07.018. Review.

8.

p38-MAPK/MSK1-mediated overexpression of histone H3 serine 10 phosphorylation defines distance-dependent prognostic value of negative resection margin in gastric cancer.

Khan SA, Amnekar R, Khade B, Barreto SG, Ramadwar M, Shrikhande SV, Gupta S.

Clin Epigenetics. 2016 Aug 31;8:88. doi: 10.1186/s13148-016-0255-9. eCollection 2016.

9.

Presenting symptoms predict local staging of anal cancer: a retrospective analysis of 86 patients.

Sauter M, Keilholz G, Kranzbühler H, Lombriser N, Prakash M, Vavricka SR, Misselwitz B.

BMC Gastroenterol. 2016 Apr 6;16:46. doi: 10.1186/s12876-016-0461-0.

10.

Prognostic role of neuroendocrine cell differentiation in human gastric carcinoma.

Zhang T, Su D, Mao Z, Guo X, Wang L, Bai L.

Int J Clin Exp Med. 2015 May 15;8(5):7837-42. eCollection 2015.

11.

D1 versus D2 dissection in gastric carcinoma: Evaluation of postoperative mortality and complications.

Vural V, Saylam B, Çomçalı B, Düzgün AP, Özer MV, Coşkun F.

Ulus Cerrahi Derg. 2013 Mar 1;29(1):1-6. doi: 10.5152/UCD.2013.01. eCollection 2013.

12.

Estimation of an optimal chemotherapy utilisation rate for upper gastrointestinal cancers: setting an evidence-based benchmark for the best-quality cancer care.

Ng W, Jacob S, Delaney G, Do V, Barton M.

Gastroenterol Res Pract. 2015;2015:753480. doi: 10.1155/2015/753480. Epub 2015 Mar 26.

13.

Bone metastasis from gastric cancer: the incidence, clinicopathological features, and influence on survival.

Turkoz FP, Solak M, Kilickap S, Ulas A, Esbah O, Oksuzoglu B, Yalcin S.

J Gastric Cancer. 2014 Sep;14(3):164-72. doi: 10.5230/jgc.2014.14.3.164. Epub 2014 Sep 30.

14.

Subtotal gastrectomy for gastric cancer.

Santoro R, Ettorre GM, Santoro E.

World J Gastroenterol. 2014 Oct 14;20(38):13667-80. doi: 10.3748/wjg.v20.i38.13667. Review.

15.

Proteinase activated-receptors-associated signaling in the control of gastric cancer.

Sedda S, Marafini I, Caruso R, Pallone F, Monteleone G.

World J Gastroenterol. 2014 Sep 14;20(34):11977-84. doi: 10.3748/wjg.v20.i34.11977. Review.

16.

Disease recurrence following cetuximab completion and declining a gastrectomy: what next to manage Ménétriers disease?

Patel M, Mottershead M.

BMJ Case Rep. 2014 Sep 1;2014. pii: bcr2014204954. doi: 10.1136/bcr-2014-204954.

17.

Timing of chemotherapy and survival in patients with resectable gastric adenocarcinoma.

Arrington AK, Nelson R, Patel SS, Luu C, Ko M, Garcia-Aguilar J, Kim J.

World J Gastrointest Surg. 2013 Dec 27;5(12):321-8. doi: 10.4240/wjgs.v5.i12.321.

18.

A novel oncolytic viral therapy and imaging technique for gastric cancer using a genetically engineered vaccinia virus carrying the human sodium iodide symporter.

Jun KH, Gholami S, Song TJ, Au J, Haddad D, Carson J, Chen CH, Mojica K, Zanzonico P, Chen NG, Zhang Q, Szalay A, Fong Y.

J Exp Clin Cancer Res. 2014 Jan 2;33:2. doi: 10.1186/1756-9966-33-2.

19.

Reduced life expectancy seen in hereditary diseases which predispose to early-onset tumors.

Evans DG, Ingham SL.

Appl Clin Genet. 2013 Jul 24;6:53-61. doi: 10.2147/TACG.S35605. Print 2013.

20.

A leathery lining.

Parikh RV, Frost N, Green A, Dandu M.

J Gen Intern Med. 2014 Jan;29(1):243. doi: 10.1007/s11606-013-2518-x. Epub 2013 Jul 17. No abstract available.

Supplemental Content

Support Center